FDA Inspection
Nomax IncFDA Inspection 1042641 - Nomax Inc - February 01, 2018
Record Details
This FDA Inspection record concerns Nomax Inc, with an inspection on February 1, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nomax Inc
- Inspection Date
- February 1, 2018
- Product Type
- Drugs
View Company Profile
ID · 95797153-fc9b-48a7-adbe-2ad6d2d1b71c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1042641
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Nomax Inc
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2026 | Not classified | Kansas City District Office | |
| February 16, 2024 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| December 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2022 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| October 27, 2016 | OAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Nomax Inc
- FDA Inspection 1315328 - 2026-02-25
- FDA Inspection 1229313 - 2024-02-16
- FDA Inspection 1194330 - 2022-12-02
- FDA Inspection 1180777 - 2022-06-24
- FDA Inspection 991448 - 2016-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.